DrugsControl Media Services

News Detail

SII writes to PMO to allow manufacturing, stockpiling of non-COVID vaccines during trial (07-03-2021)

NEW DELHI, 5 MARCH 2021: The world's largest vaccine manufacturer by volume, Serum Institute of India, has written to the Prime Minister's Office proposing reforms in the existing drug regulatory system, including allowing manufacturing and stockpiling of non-COVID vaccines while......
View Details

Source : The New Indian Express

Related News